Tokyo - Delayed Quote JPY

Euglena Co., Ltd. (2931.T)

447.00
+4.00
+(0.90%)
At close: 3:30:00 PM GMT+9
Loading Chart for 2931.T
  • Previous Close 443.00
  • Open 440.00
  • Bid --
  • Ask --
  • Day's Range 432.00 - 456.00
  • 52 Week Range 381.00 - 581.00
  • Volume 819,300
  • Avg. Volume 990,367
  • Market Cap (intraday) 60.967B
  • Beta (5Y Monthly) -0.03
  • PE Ratio (TTM) --
  • EPS (TTM) -10.06
  • Earnings Date Aug 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It also manufactures and sells foods and cosmetics using euglena. In addition, the company develops biofuel technology and environmental related technology for microalgae; and invests in biotechnology related business. Further, it produces, processes, and sells euglena, chlorella, watermelon, midori koji, etc.; and manufactures and sells organic fertilizer. Additionally, the company provides genome analysis services. Euglena Co., Ltd. was incorporated in 2005 and is headquartered in Tokyo, Japan.

www.euglena.jp

897

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 2931.T

View More

Performance Overview: 2931.T

Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

2931.T
7.71%
Nikkei 225 (^N225)
5.36%

1-Year Return

2931.T
17.38%
Nikkei 225 (^N225)
1.64%

3-Year Return

2931.T
45.15%
Nikkei 225 (^N225)
42.86%

5-Year Return

2931.T
33.38%
Nikkei 225 (^N225)
88.42%

Compare To: 2931.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2931.T

View More

Valuation Measures

Annual
As of 5/15/2025
  • Market Cap

    60.97B

  • Enterprise Value

    67.29B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.26

  • Price/Book (mrq)

    1.98

  • Enterprise Value/Revenue

    1.39

  • Enterprise Value/EBITDA

    117.85

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -2.79%

  • Return on Assets (ttm)

    0.54%

  • Return on Equity (ttm)

    -1.85%

  • Revenue (ttm)

    48.4B

  • Net Income Avi to Common (ttm)

    -1.35B

  • Diluted EPS (ttm)

    -10.06

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    19.05B

  • Total Debt/Equity (mrq)

    80.33%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 2931.T

View More

Company Insights: 2931.T

Research Reports: 2931.T

View More

People Also Watch